Last $21.84 USD
Change Today -0.46 / -2.06%
Volume 42.3K
VASC On Other Exchanges
As of 11:59 AM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

vascular solutions inc (VASC) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/4/14 - $28.21
52 Week Low
08/9/13 - $15.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

vascular solutions inc (VASC) Related Businessweek News

No Related Businessweek News Found

vascular solutions inc (VASC) Details

Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide. The company’s catheter products include GuideLiner catheters for deep-seating, back-out support, and optimal stenting in various interventions; Pronto extraction catheters for treating acute myocardial infarction; Micro-Introducers for performing arterial and venous catheterization procedures; Langston to measure intravascular pressure gradients for the diagnosis of aortic valve stenosis; and SmartNeedle, a doppler-guided needle device designed to provide auditory ultrasound-guided access to arteries and veins. It also offers Venture, a deflectable tip catheter used for steering guidewires in various interventions; Guardian, a hemostat valve used in catheterization procedures; SuperCross, a microcatheter for support and delivery of guidewires during coronary and peripheral catheterization procedures; Snares to retrieve or manipulate objects in the cardiovascular system; and Minnie, a support catheter used to facilitate placement and exchange of guidewires and other interventional devices. In addition, the company provides hemostat products comprising D-Stat Dry Thrombix, a thrombin-based hemostat bandage used to control bleeding at the site of femoral artery punctures; D-Stat Flowable, a flowable mixture to control bleeding in the pectoral pockets; Vasc Band radial hemostat, a compression device used to assist with bleeding control; D-Stat Radial, a wrist band to control bleeding at the radial artery access site; and accumed wrist positioning splint. Further, it offers vein products and services, such as Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, as well as a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The company was founded in 1996 and is headquartered in Minneapolis, Minnesota.

406 Employees
Last Reported Date: 02/4/14
Founded in 1996

vascular solutions inc (VASC) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $500.0K
Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: $265.0K
Senior Vice President of Operations
Total Annual Compensation: $340.0K
Senior Vice President of Worldwide Sales
Total Annual Compensation: $280.0K
Vice President of Marketing
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2013.

vascular solutions inc (VASC) Key Developments

Vascular Solutions, Inc. Issues Recall of Langston Dual Lumen Catheters

On May 23, 2014, Vascular Solutions Inc. initiated a voluntary nationwide recall of Langston dual lumen catheters used in catheterization procedures. The Langston dual lumen catheter is indicated for delivery of contrast medium in angiographic studies and for simultaneous pressure measurement from two sites. This type of pressure measurement is useful in determining transvalvular, intravascular, and intraventricular pressure gradients. Specific lots of the products have been recalled because of the potential for the inner catheter to separate from the hub during use and travel into the patient's circulation. This may require an intervention or surgery to retrieve the separated piece. In addition, the operator may be at increased risk of contact with contrast or bodily fluid, which could potentially result in infection or injury to the operator.

Vascular Solutions Inc. Launches Gel-Bead(TM) Embolization Spheres

Vascular Solutions Inc. announced the U.S. market launch of its Gel-Bead embolization spheres for the treatment of hypervascular tumors. Gel-Bead embolization spheres are precisely sized, bioresorbable beads of gelatin that are absorbed by the body over time, providing physicians with a treatment option for hypervascular tumors in cases when a permanent embolic agent is not desired. Gel-Bead, which received 510(k) clearance from the U.S. Food and Drug Administration in April, will be sold to interventional radiologists who currently embolize hypervascular tumors with microspheres, PVA particles, and gelatin foam slurries. Gel-Bead is supplied in 20ml syringes, each containing 1ml of gelatin spheres suspended in 5ml of saline. Gel-Bead is available in four sizes of sphere diameter (100-300 microns, 300-500 microns, 500-700 microns, and 700-1,000 microns), each identified by a different colored syringe plunger.

Vascular Solutions Inc. Presents at Deutsche Bank Securities 39th Annual Health Care Conference, May-07-2014

Vascular Solutions Inc. Presents at Deutsche Bank Securities 39th Annual Health Care Conference, May-07-2014 . Venue: The InterContinental Hotel, 510 Atlantic Ave, Boston, MA 02210, United States.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VASC:US $21.84 USD -0.46

VASC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $16.63 USD -0.15
Cardiovascular Systems Inc $29.02 USD -0.24
CryoLife Inc $9.12 USD -0.07
LeMaitre Vascular Inc $7.95 USD 0.00
Synergetics USA Inc $3.01 USD +0.01
View Industry Companies

Industry Analysis


Industry Average

Valuation VASC Industry Range
Price/Earnings 32.5x
Price/Sales 3.3x
Price/Book 3.8x
Price/Cash Flow 28.4x
TEV/Sales 3.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VASCULAR SOLUTIONS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at